CrystalGenomics Eyes COVID-19 Trials As Hopes Rise For Ivaltinostat
Also Seeking Pipeline Alliances
Although the pandemic could slightly delay CrystalGenomics’ business and R&D plans, the South Korean biotech is still hopeful this year will bring long-awaited progress for anticancer candidate ivaltinostat as well as discovery of its potential as a treatment for the new coronavirus.
